Director, Clinical Development Scientist

reputed company

About the Role

The Director, Clinical Development Scientist will be the clinical and medical primary reputed company to support the reputed company region for our reputed company program, Myasthenia Gravis (gMG).

Reporting to the Sr. Director, Clinical Development gMG reputed company, you will reputed company the preparation, review and execution of clinical study synopses and protocols, investigator brochures, and clinical study reports; review SAPs and TLF shells, guide the evaluation of emerging clinical trial data, reputed company/guide the data interpretation and data mining, and ensure assigned studies are conducted according to GCPs and SOPs. You will reputed company as the medical monitor in reputed company collaboration with the CRO medical and clinical monitors, ensure reputed company recruitment in collaboration with clinical operations, reputed company/guide in conducting literature searches and reviews, reputed company-analyses, and publishing data. You must have experience with Rare Diseases or Neurology reputed company the biotechnology or pharmaceutical industries.  

This is a unique opportunity to join a growing organization with an expanding pipeline and reputed company clinical reputed company for auto-immune neurology indications. We are building a culture of individuals who hold our reputed company principles at reputed company of our operations, with the goal to reputed company the care of our patients’ lives. We are reputed company to you working remotely.

Key Responsibilities

• Providing clinical leadership and strategic medical input for reputed company clinical deliverables in the assigned project or reputed company of a clinical program.
• Leading development of clinical sections of trial and program level regulatory documents.
• Driving execution of the program and/or clinical trial in partnership.
• Supporting the Clinical Development program reputed company by providing medical input into Clinical Development Plan (CDP) and Clinical Trial Protocol (CTP) reviews and contributing to/driving development of disease clinical standards for new disease areas.
• Literature review, KOL interactions, attending scientific meetings, and presenting the clinical development plan to the relevant internal stakeholders to help shape the new indication selection process.
• Leading the protocol development for the new selected indication/s, working closely with the relevant external and internal stakeholders
• As a medical specialist, supporting and leading interactions with external and internal partners and decision boards.
• Medical monitoring of the assigned clinical trial/s, data and safety review and working closely with the clinical operations, and external partners to reputed company conduct of the assigned clinical trial/s.
• Working closely with the reputed company stakeholders as reputed company as the clinical sites, and investigators to help ensure reputed company recruitment.

Experience

• MD, PhD, or PharmD required
• Experience in clinical development is required. Experience in rare diseases, neurology is highly preferred.
• Proven ability to work with cross functional teams, study vendors and clinical trial sites.
• Strong business communication skills, written and verbal, and comfortable with giving presentations internally and externally.
• Knowledge – thorough understanding of GCP/regulatory requirements.
• Proactiveness – the ability to identify challenges and risks and implement appropriate actions with some supervision.
• Motivation – highly motivated and self-starter; reputed company to organize and reputed company reputed company tasks with minimal supervision.
• Collaboration – to coordinate activities of internal cross-functional study team as reputed company as external vendors as applicable.
• reputed company-mindedness – listen to reputed company from others and reputed company guidance reputed company applicable; inform manager as situations reputed company to brainstorm and reputed company best solutions.